SavedAdd your journal

Journals / Solunum / 2010 / Cilt: 12 - Sayı: 3

The contribution of combined resection to survival in a patient with non-small cell lung carcinoma which has solitary synchronous cranial metastasis

Soliter senkron kranial metastazlı küçük hücreli dışı akciğer kanserli olguda kombine rezeksiyonunun sağkalıma katkısı

Evrim Eylem AKPINAR
Erkmen GÜLHAN
Hakan SABUNCUOĞLU
Meral GÜLHAN
Journal
Solunum
Pages
139–143
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we aimed to emphasize the importance of surgical treatment in similar patients, by investigating the combined surgical treatment approach in a NSCLC patient who is stage IV due to brain metastasis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Brain metastasis are seen in 1/3?rd of non-small cell lung carcinoma (NSCLC).
📊
Key Findings & Data:If brain metastasis is not treated, neurologic symptoms rapidly progress and median survival is two months.
💡
Conclusion & Impact:In this report, we aimed to emphasize the importance of surgical treatment in similar patients, by investigating the combined surgical treatment approach in a NSCLC patient who is stage IV due to brain metastasis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Brain metastasis are seen in 1/3?rd of non-small cell lung carcinoma (NSCLC). If brain metastasis is not treated, neurologic symptoms rapidly progress and median survival is two months. It is reported that surgical resection of brain metastasis and primary lung tumor provides long survival. In this report, we aimed to emphasize the importance of surgical treatment in similar patients, by investigating the combined surgical treatment approach in a NSCLC patient who is stage IV due to brain metastasis.

Özet

Küçük hücreli dışı akciğer kanserli (KHDAK) hastaların üçte birinde beyin metastazı görülür. Beyin metastazlı hasta tedavi edilmezse nörolojik semptomlar hızla ilerler ve ortalama sağkalım iki aydır. Seçilmiş bir hasta grubunda akciğer ve beyne cerrahi tedavi yaklaşımı ile uzun sağkalım elde edilebileceğini gösteren yayınlar vardır. Bu makalede, beyin metastazı nedeniyle evre IV olan bir KHDAK?li olgumuzda kombine cerrahi tedavi yaklaşımını irdeleyerek, küçük bir hasta grubu da olsa, benzer hastalarda cerrahi tedavinin önemine dikkat çekmeyi amaçladık.

🔖

Cite This Article

AKPINAR, E. E., GÜLHAN, E., SABUNCUOĞLU, H., GÜLHAN, M. (2010). The contribution of combined resection to survival in a patient with non-small cell lung carcinoma which has solitary synchronous cranial metastasis. Solunum, Cilt: 12 - Sayı: 3, 139–143. https://ajindex.com/articles/314338

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Newman SJ, Hansen HH. Proceedings: frequency,diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma. Cancer 1974;33:492-496
  2. Girard N, Cottin V, Tronc F, et al. Chemotherapy is the cornerstone of the combined surgical treatment of lung cancer with synchronous brain metastases. Lung Cancer 2006;53:51-58
  3. Andrews RJ, Gluck DS, Konchingeri RH. Surgical resection of brain metastases from lung cancer. Acta Neurochir (Wien) 1996;138: 382-389
  4. Kelly K, Bunn PA Jr. Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small celll lung cancer? Lung Cancer 1998;20:85-91
  5. Galluzzi S, Payne PM. Brain metastases from primary bronchial carcinoma: a statistical study of 741 necropsies. Br J Cancer 1956;10: 408-414
  6. Louie AV, Rodrigues G, Yaremko B, et al. Management and prognosis in synchronous solitary resected brain metastasis from non-small-cell lung cancer. Clinical Lung Cancer 2009;10:174-179; DOI:10.3816/CLC.2009.n.024 7. Sheehan JP, Sun MH, Kondziolka D, et al. Radiosurgery for non- small cell lung carcinoma metastatic to the brain: long term outcome and prognostic factors influencing patient survival time and local tumor control. J Neurosurg 2002;97:1276-1281
  7. Iwasaki A, Shirakusa T, Yoshinaga Y, et al. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor. Eur J Cardiothorac Surg 2004;26:488-493. DOI:10.1016/j.ejcts.2004.05.049 9. Socinski MA, Crowell R, Hensing TE, et al. Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:277S-289S
  8. Alcantara P, Bezjak A, Pandellano LC. Lung cancer with synchronous solitary brain metastasis: palliative or radical treatment? Rev Oncol 2004;6:397-402
  9. Modi A, Vohra HA, Weeden DF. Does surgery for primary non- small cell lung cancer and cerebral metastasis have any impact on survival? Interact CardioVasc Thorac Surg 2009;8:467-473. DOI:10.1510/icvts.2008.195776 12. Shen KR, Meyers BF, Lamer JM, et al. Special treatment ıssues in lung cancer. ACCP evidence-based clinical practice guıdelines (2nd edition). Chest 2007;132:290S-305S. DOI:10.1378/chest.07-1382 13. Flannery TW, Suntharalingam M, Regine WF, et al. Long term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery. In J Radiat Oncol Biol P